Health inequalities in People with seveRe mental Illnesses: Impact of antipsychOtic tReatments and social Inequalities on long Term phYsical health (PRIORITY).

PROJECT STATUS: Ongoing
/
START DATE AND DURATION: April 2022
Summary

People with severe mental illness (SMI) are at greater risk of developing diabetes, heart disease and strokes. We aim to examine the long-term effect of antipsychotics on these physical health outcomes in people with SMI. Using electronic primary care records, we will analyse long-term changes in antipsychotic prescription patterns. Then, we will compare people’s body weight, blood pressure and cholesterol before and after the initiation of antipsychotic treatment to understand the long-term impact on physical health. Clinical findings will help patients and their doctors understand how antipsychotics can affect physical health in the long term and inform future treatment decisions.

Partners & Collaborators

University College London

Keele University

KTH Royal Institute of Technology

University of Aberdeen

Lead Investigator
Investigating Team
Irene Peterson (UCL)
Kelvin Jordan (Keele)
Claudia Cooper (UCL)
Magnus Boman (KTH Royal Institute of Technology)
Matteo Quartagno (UCL)
Craig Ramsay (Aberdeen)
Back to top